A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt®) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study

By Phuphanich Surasak   Maria Bernard   Braeckman Rene   Chamberlain Marc  

Journal of Neuro-Oncology, Vol. 81, Iss. 2, 2007-01 ,pp. : 201-208

Springer Publishing Company

Access to resources Recommend Favorite

Lymphomatous Meningitis: Incidence, Prognosis and Treatment

By Chamberlain M.C.  

American Journal of Cancer, Vol. 1, Iss. 6, 2002-01 ,pp. : 423-434

Adis International

Access to resources Recommend Favorite

Leukemic and lymphomatous meningitis: incidence, prognosis and treatment

By C. Chamberlain Marc   Nolan Craig   E. Abrey Lauren  

Journal of Neuro-Oncology, Vol. 75, Iss. 1, 2005-10 ,pp. : 71-83

Springer Publishing Company

Access to resources Recommend Favorite

Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure

By Radeski Dejan   Cull Gavin   Cain Michael   Hackett L.   Ilett Kenneth  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 765-768

Springer Publishing Company

Access to resources Recommend Favorite

Augmentation of 1- -d-Arabinofuranosylcytosine (Ara-C) cytotoxicity in leukaemia cells by co-administration with antisignalling drugs

By Freund A.   Boos J.   Harkin S.   Schultze-Mosgau M.   Veerman G.   Peters G.J.   Gescher A.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 895-901

Elsevier

Access to resources Recommend Favorite